Pharmafile Logo
Pharmafocus logo
Advanced Search

medicines pricing

Showing 4 posts of 4 posts found.

Lilly chief: German reforms jeopardise pharma innovation

July 8, 2011
Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing

German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …

News

Price transparency and timing at risk, warns EFPIA

June 9, 2011
Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing

Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …

News

Czech reforms will cut drug spending

January 13, 2011
Sales and Marketing Czech Republic, Drug pricing, drug funding, drug spending, global pricing, healthcare reforms, medicines pricing

The Czech Republic has announced a major healthcare reform plan, including plans to restrict access to high cost new medicines. …

News

Minister confirms NICE will be sidelined in drug evaluation

October 26, 2010
Sales and Marketing Andrew Lansley, Lord Howe, NICE, PPRS, medicines pricing, value-based pricing

A health minister has confirmed NICE will be “moved” from its current central role in health technology assessment to make …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024